Skip to main content
HUMASIS CO., LTD. logo

HUMASIS CO., LTD. — Investor Relations & Filings

Ticker · 205470 ISIN · KR7205470008 KO Manufacturing
Open in API
Filings indexed 333 across all filing types
Latest filing 2021-07-28 Regulatory Filings
Country KR South Korea
Listing KO 205470

About HUMASIS CO., LTD.

https://www.humasis.com/en/

Humasis Co., Ltd. is a company specializing in the research, development, and manufacturing of in-vitro diagnostic (IVD) devices, with a primary focus on Point-of-Care Testing (POCT). The company develops and produces a range of rapid diagnostic solutions, including immunodiagnostic kits for the early screening of various diseases, compact instruments for quantitative analysis, and personal health care products. A key operational strength is the in-house development and production of critical bio-materials, such as diagnostic immune antigens, which ensures the consistent performance and accuracy of its products. Humasis aims to provide technologies for precise and rapid disease analysis to support clinical decision-making and promote individual health management.

Recent filings

Filing Released Lang Actions
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from Humasis regarding a 'Single Sale/Supply Contract' amendment. It details a change in the contract end date and provides specific financial details regarding a supply agreement for COVID-19 diagnostic kits. Since this is a specific regulatory disclosure of a material contract event that does not fit into the other specialized categories like M&A or Share Issues, it is classified as a general Regulatory Filing (RNS).
2021-07-28 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from Humasis regarding a 'Single Sale/Supply Contract' amendment. It details a contract extension for a medical diagnostic kit supply agreement. Since this is a specific disclosure of a material business contract and its amendment, it falls under the 'Regulatory Filings' category as it does not fit into more specific categories like M&A or Share Issues.
2021-07-23 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory disclosure from Humasis regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It details the contract value, counterparty (FIOCRUZ), and contract duration. Since this is a specific regulatory disclosure of a material business event (a major supply contract) that does not fit into categories like M&A, dividends, or share transactions, it is classified as a general regulatory filing.
2021-07-22 Korean
단일판매ㆍ공급계약체결(자율공시)
Regulatory Filings Classification · 95% confidence The document is a formal disclosure of a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) by Humasis. It details the contract value, the counterparty, the product (COVID-19 antigen test kits), and the contract duration. Since this is a specific regulatory disclosure regarding a commercial contract that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2021-07-13 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details a contract amendment (정정신고) for a medical device supply agreement, specifically extending the contract period. Since this is a specific regulatory disclosure regarding a material business contract and does not fit into categories like M&A, financial reports, or shareholder meetings, it falls under the general regulatory filing category.
2021-07-06 Korean
[기재정정]사업보고서 (2020.12)
Regulatory Filings Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a previously filed 'Annual Report' (사업보고서). It explicitly lists the sections being corrected (e.g., dividend information, business contracts, and management details) and provides the updated content for those sections. While it is a correction to an Annual Report, it is not the full 10-K itself, but rather a regulatory filing detailing amendments to the previously submitted 10-K. According to the classification rules, specifically the fallback for regulatory filings and the nature of the document as a formal amendment to a regulatory submission, it is classified as a Regulatory Filing (RNS). FY 2020
2021-06-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.